Evidence map›Paper›PMID 37296607›Full record

ArticleCells2023

Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASP.

Rim Bouslama, Vincent Dumont, Sonja Lindfors, Lassi Paavolainen, Jukka Tienari, Harry Nisen, Tuomas Mirtti, Moin A Saleem, Daniel Gordin, Per-Henrik Groop and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Rim BouslamaResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
Vincent DumontResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-2893-5479
Sonja LindforsResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-2024-0760
Lassi PaavolainenInstitute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0003-1508-2718
Jukka TienariDepartment of Pathology, University of Helsinki, Helsinki, and Helsinki University Hospital, 05850 Hyvinkää, Finland.
Harry NisenDepartment of Urology, Helsinki University Hospital, 00029 HUS, Finland.
Tuomas MirttiDepartment of Pathology, Helsinki University Hospital, 00290 Helsinki, Finland.ORCID 0000-0003-0455-9891
Moin A SaleemChildren's Renal Unit, Bristol Medical School, University of Bristol, Bristol BS8 1TS, UK.
Daniel GordinMinerva Foundation Institute for Medical Research, 00290 Helsinki, Finland.
Per-Henrik GroopResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
Shiro SuetsuguDivision of Biological Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma 630-0192, Japan.ORCID 0000-0002-4612-0628
Sanna LehtonenResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0003-4189-2415
University of Helsinki · FIHelsinki University Hospital · FIJoslin Diabetes Center · USNara Institute of Science and Technology · JPUniversity of Bristol · GB

Funding

Academy of Finland 1219001Academy of Finland 310552Alfred Kordelin FoundationDoctoral Programme in BiomedicineEVO governmental grantsFinnish Diabetes Research FoundationFinnish Kidney FoundationFinnish Medical FoundationFinnish-Norwegian Medical Research FoundationHiLife, University of HelsinkiHospital District of Helsinki and Uusimaa TYH2018235Jalmari and Rauha Ahokas FoundationLiv och Hälsa SocietyMaud Kuistila FoundationMedical Society of FinlandOnni and Hilja Tuovinen FoundationOrion FoundationPäivikki and Sakari Sohlberg FoundationPerklén FoundationSigrid Jusélius FoundationUniversity of HelsinkiWilhelm and Else Stockmann Foundation
6 · The paper itself

Abstract

Changes in the dynamic architecture of podocytes, the glomerular epithelial cells, lead to kidney dysfunction. Previous studies on protein kinase C and casein kinase 2 substrates in neurons 2 (PACSIN2), a known regulator of endocytosis and cytoskeletal organization, reveal a connection between PACSIN2 and kidney pathogenesis. Here, we show that the phosphorylation of PACSIN2 at serine 313 (S313) is increased in the glomeruli of rats with diabetic kidney disease. We found that phosphorylation at S313 is associated with kidney dysfunction and increased free fatty acids rather than with high glucose and diabetes alone. Phosphorylation of PACSIN2 emerged as a dynamic process that fine-tunes cell morphology and cytoskeletal arrangement, in cooperation with the regulator of the actin cytoskeleton, Neural Wiskott-Aldrich syndrome protein (N-WASP). PACSIN2 phosphorylation decreased N-WASP degradation while N-WASP inhibition triggered PACSIN2 phosphorylation at S313. Functionally, pS313-PACSIN2 regulated actin cytoskeleton rearrangement depending on the type of cell injury and the signaling pathways involved. Collectively, this study indicates that N-WASP induces phosphorylation of PACSIN2 at S313, which serves as a mechanism whereby cells regulate active actin-related processes. The dynamic phosphorylation of S313 is needed to regulate cytoskeletal reorganization.

Indexed as

CaseinsPodocytesAnimalsNeuronsPhosphorylationRatsSerineCaseinsSerineactin cytoskeletondiabetic kidney diseaseFFAN-WASPPACSIN2podocytesyndapin2

Identifiers

PMID37296607
PMCPMC10252800
OpenAlexW4378529299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.